featured
Long-Term Efficacy and Safety Results of Pembrolizumab for Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Ann. Oncol 2022 Dec 06;[EPub Ahead of Print], AV Balar, DE Castellano, P Grivas, DJ Vaughn, T Powles, J Vuky, Y Fradet, JL Lee, L Fong, NJ Vogelzang, MA Climent, A Necchi, DP Petrylak, ER Plimack, JZ Xu, K Imai, BH Moreno, J Bellmunt, R de Wit, PH O'DonnellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.